The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force

Journal article

Timothy G Berger, Madeleine Duvic, Abby S Van Voorhees, Marta J VanBeek and Ilona J Frieden

Journal of the American Academy of Dermatology, Vol.54(5), pp.818-823

05/2006

DOI: 10.1016/j.jaad.2006.01.054

PMID: 16635663

View Online

no abstract

United States

Safety

Humans

Immunosuppressive Agents - therapeutic use

Risk Factors

Clinical Trials as Topic

Tacrolimus - analogs & derivatives

Tacrolimus - adverse effects

Calcineurin Inhibitors

Tacrolimus - therapeutic use

Dermatitis, Atopic - drug therapy

Neoplasms - chemically induced

Immunosuppressive Agents - adverse effects

Administration, Topical

Immunosuppressive Agents - administration & dosage

United States Food and Drug Administration

Tacrolimus - administration & dosage

Title: Subtitle: The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force
Creators: Timothy G Berger - Department of Dermatology, University of California, San Francisco, California, USA. vlebrun@aad.org
Madeleine Duvic
Abby S Van Voorhees
Marta J VanBeek
Ilona J Frieden
Resource Type: Journal article
Publication Details: Journal of the American Academy of Dermatology, Vol.54(5), pp.818-823
DOI: 10.1016/j.jaad.2006.01.054
PMID: 16635663
NLM abbreviation: J Am Acad Dermatol
ISSN: 0190-9622
eISSN: 1097-6787
Publisher: United States
Language: English
Date published: 05/2006
Academic Unit: Dermatology
Record Identifier: 9984025309302771

34 Record Views